Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Star Therapeutics Gains $125m Series D Funds to Develop Pipeline

Summary by Pharmaceutical-technology.com
Star Therapeutics has completed a Series D funding round, raising $125m, aimed at supporting its pipeline progression.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

pharmaceutical-technology.compharmaceutical-technology.com

Star Therapeutics gains $125m Series D funds to develop pipeline

Star Therapeutics has completed a Series D funding round, raising $125m, aimed at supporting its pipeline progression.

Read Full Article
endpoints.newsendpoints.news

Star gets $125M Series D as it begins Phase 3 in bleeding disorders

Star Therapeutics patched together a $125 million Series D in what it thinks is pharma's next big therapeutic category. The South San Francisco startup expects the funds to add a few years of runway and ...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

endpoints.news broke the news in on Tuesday, September 30, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Startups icon

Startups

South San Francisco icon

South San Francisco

News
For You
SearchBlindspotLocal